Challenges in Pharma Manufacturing Landscape
The pharmaceutical industry faces unprecedented challenges in today's complex landscape. From geopolitical tensions to disruptions in the supply chain caused by the pandemic, companies are under immense pressure to navigate these obstacles while meeting the growing demand for faster time-to-market solutions. A recent study by FT Longitude, involving insights from 400 experts in drug development and manufacturing, as well as professionals from renowned companies like GSK, Roche, Merck KGaA (Darmstadt Germany), and Kashiv BioSciences, sheds light on the future direction of drug manufacturing in the next 3-5 years.
Digital Transformation in Pharma Industry
In response to these challenges, pharmaceutical companies are increasingly prioritizing digital transformation initiatives. The webinar featuring Andrea Corona from Pharma Manufacturing and Chanice Henry, senior editor at FT Longitude, discusses the evolution of cultural maturity in tech adoption within pharma companies. It highlights the existing gaps, especially at the C-suite level, and provides specific recommendations on how companies can enhance operational agility and efficiency through digital technologies.
Driving Success Through Data and Technology
Forward-thinking pharma companies are leveraging data, cultural shifts, and digital technology to position themselves for success. By embracing these elements, companies can navigate the complexities of the industry, streamline operations, and ultimately achieve their business goals. The report based on a survey of industry professionals in the US and Europe, coupled with insights from industry leaders, offers valuable insights into the future of digital transformation and manufacturing in the pharmaceutical sector.